Home › Funds › Archon Capital Management LLC › BBNX
Archon Capital Management LLC position in BBNX
BETA BIONICS INC · Health Care
Archon Capital Management LLC reported holding 83,873 shares of BBNX (BETA BIONICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.81% of its reported portfolio and ranking #31 among its reported holdings. Archon Capital Management LLC has disclosed BBNX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Archon Capital Management LLC's BBNX position evolved
Archon Capital Management LLC first disclosed a stake in BBNX in Q2 2026 at 53,873 shares (US$844K). The position peaked in Q3 2026 at 83,873 shares, worth US$1.6M. Across 2 filings, Archon Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 83,873 shares valued at US$1.6M — an increase of 30,000 shares quarter over quarter.. Notable position changes include a 56% increase in Q3 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 53.87K | $844.19K | New |
| Q3 2026 | 83.87K | $1.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBNX and 13F data
BBNX (BETA BIONICS INC) is a Health Care company. 55 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$133.7M), Sands Capital Alternatives, LLC (US$75.9M), Soleus Capital Management, L.P. (US$68.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBNX
- EVENTIDE ASSET MANAGEMENT, LLC 7.04M sh · $133.72M · Q3 2026
- Sands Capital Alternatives, LLC 4.00M sh · $75.88M · Q3 2026
- Soleus Capital Management, L.P. 4.39M sh · $68.85M · Q2 2026
- Vestal Point Capital, LP 1.60M sh · $25.07M · Q2 2026
- Eversept Partners, LP 1.02M sh · $19.43M · Q3 2026
- Omega Fund Management, LLC 962.01K sh · $18.26M · Q3 2026
- Divisadero Street Capital Management, LP 1.11M sh · $17.45M · Q2 2026
- Bruce & Co., Inc. 665.70K sh · $12.63M · Q3 2026
- PURA VIDA INVESTMENTS, LLC 281.16K sh · $4.41M · Q2 2026
More on Archon Capital Management LLC
FAQ
How long has Archon Capital Management LLC held BBNX?
Archon Capital Management LLC has disclosed BBNX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Archon Capital Management LLC's current position in BBNX?
As of Q3 2026, Archon Capital Management LLC holds 83.87K shares of BBNX (BETA BIONICS INC), valued at $1.59M, representing 0.81% of its reported portfolio and ranking #31.
Has Archon Capital Management LLC been buying or selling BBNX?
In the latest 13F filing (Q3 2026), Archon Capital Management LLC increased its position in BBNX. The position peaked in Q3 2026 at 83.87K shares.
Which other funds hold BBNX?
Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.